GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Equity-to-Asset

Kindstar Globalgene Technology (HKSE:09960) Equity-to-Asset : 0.76 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kindstar Globalgene Technology's Total Stockholders Equity for the quarter that ended in Jun. 2024 was HK$3,116 Mil. Kindstar Globalgene Technology's Total Assets for the quarter that ended in Jun. 2024 was HK$4,122 Mil. Therefore, Kindstar Globalgene Technology's Equity to Asset Ratio for the quarter that ended in Jun. 2024 was 0.76.

The historical rank and industry rank for Kindstar Globalgene Technology's Equity-to-Asset or its related term are showing as below:

HKSE:09960' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.25   Med: 0.76   Max: 0.85
Current: 0.76

During the past 6 years, the highest Equity to Asset Ratio of Kindstar Globalgene Technology was 0.85. The lowest was -2.25. And the median was 0.76.

HKSE:09960's Equity-to-Asset is ranked better than
71.93% of 228 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.63 vs HKSE:09960: 0.76

Kindstar Globalgene Technology Equity-to-Asset Historical Data

The historical data trend for Kindstar Globalgene Technology's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Equity-to-Asset Chart

Kindstar Globalgene Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial -1.21 -1.17 0.85 0.76 0.78

Kindstar Globalgene Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.82 0.76 0.77 0.78 0.76

Competitive Comparison of Kindstar Globalgene Technology's Equity-to-Asset

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kindstar Globalgene Technology's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's Equity-to-Asset falls into.


;
;

Kindstar Globalgene Technology Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Kindstar Globalgene Technology's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=3141.324/4013.303
=0.78

Kindstar Globalgene Technology's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=3116.325/4122.384
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kindstar Globalgene Technology  (HKSE:09960) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Kindstar Globalgene Technology Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindstar Globalgene Technology Business Description

Traded in Other Exchanges
N/A
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.
Executives
Cpechina Fund Iii, L.p. 2201 Interest of corporation controlled by you
Ck Lab Tech Investment Limited 2101 Beneficial owner
Cpe Funds Iii Limited 2201 Interest of corporation controlled by you
Cpe Holdings International Limited 2201 Interest of corporation controlled by you
Cpe Holdings Limited 2201 Interest of corporation controlled by you
Huang Shiang 2101 Beneficial owner
Tu Zanbing
Huang Zuie-chin 2101 Beneficial owner
Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd.
Jackson Hole Trust Company
Huang Bo
Kernelstar Limited 2301 Trustee
Kastle Limited 2301 Trustee
Guo Gui-rong 2202 Interest of your spouse
Morningside Holdings (asia) Limited 2201 Interest of corporation controlled by you

Kindstar Globalgene Technology Headlines

No Headlines